Simultaneous determination of vitamins A, E and 25-OH-vitamin D: Application in clinical assessments

2006 ◽  
Vol 39 (2) ◽  
pp. 180-182 ◽  
Author(s):  
F. Granado-Lorencio ◽  
B. Olmedilla-Alonso ◽  
C. Herrero-Barbudo ◽  
I. Blanco-Navarro ◽  
S. Blázquez-García ◽  
...  
2017 ◽  
Vol 63 (02/2017) ◽  
Author(s):  
Eva Klapkova ◽  
Jana Cepova ◽  
Marta Pechova ◽  
Katerina Dunovska ◽  
Karel Kotaska ◽  
...  

Nutrients ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 2271 ◽  
Author(s):  
Jennifer Gjerde ◽  
Marian Kjellevold ◽  
Lisbeth Dahl ◽  
Torill Berg ◽  
Annbjørg Bøkevoll ◽  
...  

Vitamin D deficiency in pregnant women and their offspring may result in unfavorable health outcomes for both mother and infant. A 25hydroxyvitamin D (25(OH)D) level of at least 75 nmol/L is recommended by the Endocrine Society. Validated, automated sample preparation and liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods were used to determine the vitamin D metabolites status in mother-infant pairs. Detection of 3-Epi25(OH)D3 prevented overestimation of 25(OH)D3 and misclassification of vitamin D status. Sixty-three percent of maternal 25(OH)D plasma levels were less than the recommended level of 25(OH)D at 3 months. Additionally, breastmilk levels of 25(OH)D decreased from 60.1 nmol/L to 50.0 nmol/L between six weeks and three months (p < 0.01). Furthermore, there was a positive correlation between mother and infant plasma levels (p < 0.01, r = 0.56) at 3 months. Accordingly, 31% of the infants were categorized as vitamin D deficient (25(OH)D < 50 nmol/L) compared to 25% if 3-Epi25(OH)D3 was not distinguished from 25(OH)D3. This study highlights the importance of accurate quantification of 25(OH)D. Monitoring vitamin D metabolites in infant, maternal plasma, and breastmilk may be needed to ensure adequate levels in both mother and infant in the first 6 months of infant life.


2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Muhammad Jehangir ◽  
Mahmood Ahmed ◽  
Muhammad Imtiaz Shafiq ◽  
Abdul Samad ◽  
Iftikhar-ul-Haq

A newly developed method based on ultrahigh performance liquid chromatography (UHPLC) was optimized for the simultaneous determination of vitamin D3and menaquinone-7 (MK-7) in tablet formulation in the present study. UHPLC separation of vitamin D3and MK-7 was performed with ACE Excel 2 C18-PFP column (2 μm, 2.1×100 mm) at 0.6 mL min−1flow rate, whereas the mobile phase consisted of methanol/water (19:1, v/v, phase A) and isopropyl alcohol (99.9%, phase B) containing 0.5% triethylamine. Isocratic separation of both the analytes was performed at 40°C by pumping the mobile phases A and B in the ratio of50:50(v/v, pH, 6.0). Both analytes were detected at a wavelength of 265 nm and the injection volume was 1.0 μL. The overall runtime per sample was 4.5 min with retention time of 1.26 and 3.64 min for vitamin D3and MK-7, respectively. The calibration curve was linear from 5.0 to 100 μg mL−1for vitamin D3and MK-7 with a coefficient of determination (R2)≥0.9981, while repeatability and reproducibility (expressed as relative standard deviation) were lower than 1.46 and 2.21%, respectively. The proposed HPLC method was demonstrated to be simple and rapid for the determination of vitamin D3and MK-7 in tablets.


1978 ◽  
Vol 48 ◽  
pp. 287-293 ◽  
Author(s):  
Chr. de Vegt ◽  
E. Ebner ◽  
K. von der Heide

In contrast to the adjustment of single plates a block adjustment is a simultaneous determination of all unknowns associated with many overlapping plates (star positions and plate constants etc. ) by one large adjustment. This plate overlap technique was introduced by Eichhorn and reviewed by Googe et. al. The author now has developed a set of computer programmes which allows the adjustment of any set of contemporaneous overlapping plates. There is in principle no limit for the number of plates, the number of stars, the number of individual plate constants for each plate, and for the overlapping factor.


Sign in / Sign up

Export Citation Format

Share Document